Mitochondrial Dysfunction in Astrocytes: A Role in Parkinson’s Disease?

77Citations
Citations of this article
117Readers
Mendeley users who have this article in their library.

Abstract

Mitochondrial dysfunction is a hallmark of Parkinson’s disease (PD). Astrocytes are the most abundant glial cell type in the brain and are thought to play a pivotal role in the progression of PD. Emerging evidence suggests that many astrocytic functions, including glutamate metabolism, Ca2+ signaling, fatty acid metabolism, antioxidant production, and inflammation are dependent on healthy mitochondria. Here, we review how mitochondrial dysfunction impacts astrocytes, highlighting translational gaps and opening new questions for therapeutic development.

Cite

CITATION STYLE

APA

Bantle, C. M., Hirst, W. D., Weihofen, A., & Shlevkov, E. (2021, January 7). Mitochondrial Dysfunction in Astrocytes: A Role in Parkinson’s Disease? Frontiers in Cell and Developmental Biology. Frontiers Media S.A. https://doi.org/10.3389/fcell.2020.608026

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free